We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » House Committee Seeks More Info on FDA’s Heparin Investigations
House Committee Seeks More Info on FDA’s Heparin Investigations
Republican leaders from the House Energy and Commerce Committee have asked the FDA to provide all documents related to the agency’s criminal investigations into the heparin contamination crisis, which stemmed from Chinese manufacturing facilities.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor